Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.302 USD | -8.73% | -5.03% | -95.49% |
04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
- Stock Market
- Equities
- GRI Stock
- Charts GRI BIOPAR
- Static Chart